Mirum Pharmaceuticals

MIRMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.535 B

$100.65 +6.94%

Close of 7 Aug 2026

Revenue

$521.3M

#1891 by revenue

Earnings

-$23.4M

Loss-making

Shares outstanding

64,932,203

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#46Tg TherapeuticsTGTX$7.62B
#47Cogent BiosciencesCOGT$7.24B
#48Mirum PharmaceuticalsMIRM$6.54B
#49Belite BioBLTE$6.41B
#50ErascaERAS$6.30B

Where these numbers come from

Share counts and financials for Mirum Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.